Functional residual capacity in healthy infants aged 1-24 months using the baby body plethysmography (CareFusion TM)

Jeremie Marie  Abratique-del Rosario,; Leanne  B. Santos,; Lallaine  Columna,; Cerissa  Caringal,; Rigmor  R. Dygico,; Liwayway  Icawat,; Jerickson  A. Bayani,; Mary Ann  F. Aison,; Rom Paulo  Marcelino,

Functional residual capacity in healthy infants aged 1-24 months using the baby body plethysmography (CareFusion TM)

Discipline: medicine by specialism

Abstract:

BACKGROUND: The only lung volume that can be measured reliably in infants is the functional residual capacity (FRC). Published reference values vary, thus, there is a need to determine values for healthy infants using the available equipment. OBJECTIVES: To determine the normal values of FRC in healthy infants using the baby body plethysmogram (CareFusion) and to determine the correlation between FRC and weight, length, age, and gender. METHODS: FRC was measured using the CareFusion MasterScreen baby body plethysmogram in 62 healthy infants aged 1-24 months old. FRC was measured after sedation with Chloral hydrate at 50 mg/kg body weight. Three measurements were performed from which the mean (SD) FRC was calculated. To depict the change in FRC with growth, regression analysis between FRC as dependent variable and weight, length, and age as independent variables was done. RESULTS: Among 62 infants, mean age was 10.97 months (range=1-24 mos), mean weight was 7.93 kg (range=4.5-12 kg) and mean length was 71.91 cm (range=56-90 cm). Thirty-one (50%) are males and 31 (50%) are females. Mean FRC (SD) was 24.56 ml/kg (4.41). Correlation of FRC with age was significant (R=0.820), as well as the weight (R=0.830) and the length (R=0.758). There was no difference in FRC between males and females. CONCLUSION: The FRC values obtained in this study is 24.56 ml/kg (4.41). There is a direct correlation of FRC with age, weight, and length. The result of this study was comparable to other studies and may be used as a reference value for healthy infants.

References:

Hofhuis W. Clinical Applications of Infant Lung Function Testing. Uylenburgh Pers, Amsterdam. 2004.
Stocks J, Quainter H. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on lung volume measurements. Official statement of the European Respiratory Society. Eur Respir J 1995; 8:492–506.
Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R. Standards for infant respiratory function testing: plethysmographic measurements of lung volume and airway resistance. Eur Respir J 2001; 17:302–312.
Merkus P.J.F.M, Jongste J.C., Stocks J. Respiratory function measurements in infants and children. Eur Respir Mon 2005; 31:166–194.
Criee CP, Sorichter S, Smith HJ, Kardos P, Merget R, Heise D, et al. Body plethysmography – Its principles and clinical use. Respir Med 2011; 105:959–971.
Coates AL, Peslin R, Rodenstein D, Stocks J. Measurement of lung volumes by plethysmography. Eur Respir J 1997; 10:1415–1427.
Stocks J, Godfrey S. Plethysmographic measurements of lung volume and airway resistance. Standards for infant respiratory function testing: ERS/ATS Task force. Eur Respir J 2001; 17:302–312.
Hulskamp G, Hoo AF, Ljungberg H, Lum S, Pillow J, Stocks J. Progressive decline in plethysmographic lung volumes in infants: physiology or technology? Am J Respir Crit Care Med 2003; 168:1003–1009.
Gaultier C, Fletcher M, Beardsmore C, Motoyama E, Stocks J. Infant Respiratory Function Testing. 1^st ed. New York: John Wiley & Sons, Inc.; 1996:29–44.
Gaultier C, Fletcher M, Beardsmore C, Motoyama E. Respiratory function measurements in infants: measurement conditions. Report of working group/ERS-ATS statement. Eur Respir J 1995; 8:1057–1066.
Ren C, Robinson P, Ranganathan S. Chloral hydrate sedation for infant pulmonary function testing. Pediatr Pulmonol 2014; 49(12):1251–1252.
Kraus B, Green SM. Sedation and analgesia for procedures in children. N Engl J Med 2000; 342:938–945.
Lipshitz M, Marino BL, Sanders ST. Chloral hydrate side effects in young children: causes and management. Heart Lung 1993; 22(5):408–414.
Greenberg SB, Faerber EN, Aspinall CL, Adams RC. High-dose chloral hydrate sedation for children undergoing MR imaging: safety and efficacy in relation to age. AJR Am J Roentgenol 1993; 161(3):639–641.
Valenzuela DG, Kumar DS, Atkins CL, Beers A, Kozak FK, Chadna NK. Chloral hydrate sedation for auditory brainstem response (ABR) testing in children: safety and effectiveness. Int J Pediatr Otorhinolaryngol 2016; 83:175–178.
Wilson ME, Karaoui M, Al Djasim L, Edward DP, Al Shamrani M, Friedman DS. The safety and efficacy of chloral hydrate sedation for pediatric ophthalmic procedures: a retrospective review. J Pediatr Ophthalmol Strabismus 2014; 51(3):154–159.
American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202–1218.
Cote CJ, Wilson S. Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016. American Academy of Pediatrics 2016.
CareFusion Germany. Instructions for Use – MasterScreen Paed/Baby Body. 2013.
Pitcher-Wilmott R, Shutack, Fox W. Decreased lung volume after nasogastric feeding of neonates recovering from respiratory disease. J Pediatr 1979; 95:119–121.
Taussig LM, Harris TR, Lebowitz MD. Lung function in infants and young children. Am Rev Respir Dis 1977; 116:233–239.
Wall MA, Misley MC, Dickerson D. Partial expiratory flow volume curves in young children. Am Rev Respir Dis 1984; 129:557–562.